Biotech · Private company
Academic Thoracic Oncology Medical Investigators Consortium
Track this companyFree. Adds Academic Thoracic Oncology Medical Investigators Consortium to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- durvalumabPhase 2 · Non-Small Cell Lung Cancer NSCLCClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Nab paclitaxelPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Oral Tablet: CabozantinibPhase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal CancerPHASE2 · COMPLETED · started Jun 1, 2018ClinicalTrials.gov NCT03542877 · fetched Nov 12, 2026
- A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer PatientsPHASE2 · COMPLETED · started Apr 4, 2017ClinicalTrials.gov NCT02879617 · fetched Nov 12, 2026
- Trial of Brigatinib After Treatment With Next-Generation ALK InhibitorsPHASE2 · TERMINATED · started Mar 9, 2017ClinicalTrials.gov NCT02706626 · fetched Nov 12, 2026
- Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular CorrelatesPHASE2 · COMPLETED · started Dec 30, 2016ClinicalTrials.gov NCT02723331 · fetched Nov 12, 2026